Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06076863 · ClinicalTrials.gov registry record · NA
Pharmacist Management of Paxlovid eVisits
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 2,478
- Enrollment target
NCT06076863: Completed NA study, sponsored by Kaiser Permanente.
NCT06076863 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 2,478 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06076863, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,478 participants
- Enrollment target
Study Summary
The goal of this cluster randomized trial is to compare two modes of management -- pharmacist care vs. pooled adult and family medicine physician care -- for electronically submitted requests (e-visits) for Paxlovid by adults with COVID-19. It will compare quality of care based on counseling for common potential drug-drug interactions and time to prescription, as well as the time and financial costs of care in the two groups.
Primary Outcome
Whether or not a patient with one or more common potential drug-drug interactions with Paxlovid received counseling, as documented in the electronic health record, with data collected via review of text extracts from the EHR
Interventions
- OTHER Pharmacist Care
- OTHER AFM Pool Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,478 participants |
| Start Date | 2023-10-09 |
| Est. Completion | 2024-01-11 |
| Phase | NA |
What the finished NCT06076863 record still lists
NCT06076863 is an interventional study that assigns participants to a tested intervention. Its 2,478 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% higher).
The record links to 0 conditions, and to 2 interventions - of which Pharmacist Care is the first listed.
NCT06076863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06076863 about?
NCT06076863 is a clinical study titled "Pharmacist Management of Paxlovid eVisits". The goal of this cluster randomized trial is to compare two modes of management -- pharmacist care vs. pooled adult and family medicine physician care -- for electronically submitted requests (e-visits) for Paxlovid by adults with COVID-19. It will compare quality of care based on counseling for com...
What is the current status of trial NCT06076863?
This trial is currently completed. It is a NA study. The enrollment target is 2,478 participants. The study started on 2023-10-09. Estimated completion is 2024-01-11.
What interventions are being tested in trial NCT06076863?
The interventions under investigation include: Pharmacist Care (OTHER), AFM Pool Care (OTHER).
Who is sponsoring clinical trial NCT06076863?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06076863's enrollment target sits among peer trials
2,478 45th of 2000 higher than 1,956 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI